Amphastar Pharmaceuticals, Inc.
AMPH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $217 | $188 | $183 | $152 |
| Short-Term Investments | $62 | $44 | $54 | $70 |
| Receivables | $147 | $135 | $145 | $138 |
| Inventory | $186 | $192 | $185 | $154 |
| Other Curr. Assets | $28 | $23 | $20 | $21 |
| Total Curr. Assets | $639 | $581 | $588 | $534 |
| Property Plant & Equip (Net) | $354 | $355 | $354 | $345 |
| Goodwill | $3 | $3 | $3 | $3 |
| Intangibles | $569 | $575 | $581 | $588 |
| Long-Term Investments | $0 | $2 | $6 | $11 |
| Tax Assets | $71 | $71 | $71 | $71 |
| Other NC Assets | $30 | $28 | $23 | $26 |
| Total NC Assets | $1,027 | $1,035 | $1,038 | $1,043 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,666 | $1,615 | $1,626 | $1,577 |
| Liabilities | – | – | – | – |
| Payables | $41 | $42 | $53 | $31 |
| Short-Term Debt | $9 | $9 | $8 | $7 |
| Tax Payable | $0 | $1 | $15 | $10 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $156 | $125 | $123 | $127 |
| Total Curr. Liab. | $205 | $176 | $199 | $174 |
| LT Debt | $648 | $647 | $645 | $644 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $7 | $7 | $7 |
| Other NC Liab. | $36 | $28 | $24 | $21 |
| Total NC Liab. | $684 | $681 | $676 | $671 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $39 | $47 | $48 | $49 |
| Total Liabilities | $889 | $858 | $875 | $845 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | $642 | $625 | $594 | $569 |
| AOCI | -$5 | -$5 | -$8 | -$9 |
| Other Equity | $140 | $138 | $165 | $173 |
| Total Equity | $777 | $757 | $751 | $732 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,666 | $1,615 | $1,626 | $1,577 |
| Net Debt | $440 | $468 | $470 | $499 |